These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 60303)
1. Defective cell-mediated immunity in carcinoma of the prostate. Thomas JW; Jerkins G; Cox C; Lieberman P Invest Urol; 1976 Jul; 14(1):72-5. PubMed ID: 60303 [TBL] [Abstract][Full Text] [Related]
2. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation. Simmler MC; Rameau G; Chou MJ; Mathé G Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695 [TBL] [Abstract][Full Text] [Related]
3. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay. van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334 [TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of lymphocyte functions in urological cancer patients. Elhilali MM; Paika KD; Brosman S; Fahey JL Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369 [TBL] [Abstract][Full Text] [Related]
5. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma. Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280 [TBL] [Abstract][Full Text] [Related]
6. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes. Catalona WJ; Tarpley JL; Potvin C; Chretien PB Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390 [TBL] [Abstract][Full Text] [Related]
7. Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. Brannen GE; Coffey DS Cancer Treat Rep; 1977; 61(2):211-6. PubMed ID: 68825 [TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity in patients with nodular hyperplasia and carcinoma of the prostate. Leńko J; Turowski G; Dobrowolski Z Acta Med Pol; 1983; 24(1-4):93-101. PubMed ID: 6207706 [No Abstract] [Full Text] [Related]
9. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer. Lopez DM; Voigt W Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055 [TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro cell-mediated immunity in tuberculous meningitis. El-Naggar AK; Higashi GI J Clin Lab Immunol; 1982 May; 8(1):37-42. PubMed ID: 7047745 [TBL] [Abstract][Full Text] [Related]
11. Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH. Kastelan M; Kovacić K; Tarle R; Kraljić I; Tarle M Anticancer Res; 1997; 17(3B):1671-5. PubMed ID: 9179216 [TBL] [Abstract][Full Text] [Related]
12. [Controlled study of unspecific cellular immunity in cancer patients]. Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418 [TBL] [Abstract][Full Text] [Related]
13. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil]. Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435 [TBL] [Abstract][Full Text] [Related]
14. Effect of transfer factor on lymphocyte function in anergic patients. Kirkpatrick CH; Rich RR; Smith TK J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419 [TBL] [Abstract][Full Text] [Related]
15. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Lim M; Weber CE; Baccala AA; Goemann MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF; Nelson WG Cancer Res; 1999 Oct; 59(20):5160-8. PubMed ID: 10537292 [TBL] [Abstract][Full Text] [Related]
16. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis. Elliott ST; Hanifin JM Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287 [TBL] [Abstract][Full Text] [Related]
17. An in vitro study of depressed cell-mediated immunity and of T and B lymphocytes in atopic dermatitis. Hovmark A Acta Derm Venereol; 1977; 57(3):237-42. PubMed ID: 71829 [TBL] [Abstract][Full Text] [Related]
18. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function. Roth JA; Golub SH; Grimm EA; Eilber FR; Morton DL Surgery; 1976 Jan; 79(1):46-51. PubMed ID: 128842 [TBL] [Abstract][Full Text] [Related]
19. Lymphocyte populations and cellular immune reactions in juvenile rheumatoid arthritis. Hoyeraal HM; Froland SS; Wisloff F Scand J Immunol; 1975; 4(8):801-10. PubMed ID: 1082632 [TBL] [Abstract][Full Text] [Related]
20. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies. Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]